Market Tracker

09/28 2:52pm ET

OPKO Health Inc (NASDAQ:OPK)

10.93
BATS BZX Real-Time Price
As of 2:52pm ET
 -0.265 / -2.37%
Today’s Change
7.12
Today|||52-Week Range
11.85
+8.71%
Year-to-Date
Insiders Cannot Get Enough Of Endurance International And Opko Health
9:44am / Benzinga - Paid Partner Content
Weekly CEO Buys Highlights
Sep 26 / GuruFocus News - Paid Partner Content
Opko Health Has Big News on Deck
Sep 27 / MotleyFool.com - Paid Partner Content
3 Stocks That Turned $5,000 Into $50,000 or More
Sep 15 / MotleyFool.com - Paid Partner Content

Today’s Trading

Previous close11.19
Today’s open11.14
Day’s range10.83 - 11.17
Volume221,417
Average volume (3 months)3,287,690
Market cap$6.2B
Dividend yield--
Data as of 2:52pm ET, 09/28/2016

Growth & Valuation

Earnings growth (last year)+85.37%
Earnings growth (this year)-23.33%
Earnings growth (next 5 years)0.00%
Revenue growth (last year)+439.63%
P/E ratio37.0
Price/Sales9.97
Price/Book3.08

Competitors

 Today’s
change
Today’s
% change
ALNYAlnylam Pharmaceutic...-1.37-1.75%
TSROTESARO Inc-3.68-3.41%
UTHRUnited Therapeutics ...-4.34-3.56%
ENDPEndo International P...-0.03-0.13%
Data as of 2:52pm ET, 09/28/2016

Financials

Next reporting dateNovember 7, 2016
EPS forecast (this quarter)-$0.03
Annual revenue (last year)$491.7M
Annual profit (last year)-$30.0M
Net profit margin-6.11%

Profile

Sector
Health Technology
Industry
Biotechnology
Chairman &
Chief Executive Officer
Phillip Frost
Chief Financial Officer, Treasurer, CAO &
SVP
Adam E. Logal
Corporate headquarters
Miami, Florida

Forecasts